Specific tests for Alzheimer’s disease (AD) diagnosis are currently unavailable, despite AD being the leading cause of dementia. One hallmark of AD progression is the aggregation of tau proteins into paired helical filaments and neurofibrillary tangles, which is accelerated by the hyperphosphorylation of Tau proteins. However, the mechanism by which the hyperphosphorylated tau accelerates protein aggregation is not completely understood. Furthermore, detecting and disrupting such aggregated forms through the blood-brain barrier (BBB) remains a significant bottleneck in developing AD diagnostics and therapeutics. At the same time, quantum dots (QDs) have shown tremendous potential in penetrating the BBB to diagnose brain cancer, as well as detecting and disrupting protein aggregates in other neurodegenerative diseases such as Parkinson’s disease. QDs are an attractive diagnostic material due to their fluorescence-emitting capabilities, nanoscale size that allows penetration of the BBB, chemical stability, solubility, and facile synthesis. However, QDs have not yet been assessed for their ability to detect and disrupt hyperphosphorylated tau tangles. Hence, the aims of this project are two-fold: 1) to unravel the mechanisms and energetic barriers of normal and hyperphosphorylated tau protein aggregation by building three-dimensional atomistic models of aggregated structures and performing classical and enhanced sampling molecular dynamics simulations on these models; 2) to predict the potential of QDs in binding to and disrupting hyperphosphorylated tau tangles though polarized ligand docking and free-energy calculations. Upon identification of potential QD-binding signatures, these QDs will be synthesized and tested in vitro and in vivo through collaborative efforts with the goal of translating this work into clinical diagnostic applications for AD in the future.
Figure 1. Microtubule-associated protein tau (MAPT) functions in the healthy brain (left) and a brain with Alzheimer’s disease (AD) (right). Self-association and excessive post-translational modifications of Tau proteins result in the formation of neurofibrillary tangles and cause neurodegeneration in AD patients. Targeting the tau aggregates using Quantum Dots could help develop potential diagnostics and/or therapeutics for AD.
Related Content

Molecular Scale Magnetic Resonance Imaging
Through its phenomenal ability to image soft tissues, magnetic resonance imaging (MRI) has revolutionized both clinical medicine and research biomedicine.
September 9, 2016

Hybrid Quantum Materials towards Topological Quantum Computing
Summary Proximity engineered hybrid materials have shown promise for topological quantum information processing. This form of quantum computing provides a stable, error-tolerant approach for building scalable quantum information processors. Topological quantum computing relies on braiding non-Abelian particles, such as Majorana fermions, which do not exist in nature. One can however use materials engineering to […]
December 8, 2018

Tuning Spin-Exchange Interactions in Low-Dimensional Metal Halide Perovskites: A New Class of Semiconductor Quantum Materials
Summary Leakage current in electronic components is one of the limiting factors for the performance of conventional computers which use charges and currents as physical information carriers. Spintronics offers an alternative by using electron spin for information transfer, processing and storage, enabling the design of non-volatile computer memory and more energy-efficient electronic devices. In this […]
October 1, 2019

Applications of Neutron Interferometry and Structured Neutron Beams
Summary Neutrons are a powerful probe of matter and physics due to their Angstrom size wavelengths, electric neutrality and relatively large mass. In this project, we develop quantum sensors that exploit these attributes to increases the precision of measurements of fundamental forces and materials structure. With David Cory, Alexander Cronin of the University of Arizona, […]
July 31, 2018